HomeCompareRMD vs ET

RMD vs ET: Dividend Comparison 2026

RMD yields 1.06% · ET yields 6.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ET wins by $61.7K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
ET
ET
● Live price
6.76%
Share price
$19.59
Annual div
$1.33
5Y div CAGR
24.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.4K
Annual income
$21,965.29
Full ET calculator →

Portfolio growth — RMD vs ET

📍 ET pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDET
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + ET cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
ET pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
ET
Annual income on $10K today (after 15% tax)
$574.91/yr
After 10yr DRIP, annual income (after tax)
$18,670.50/yr
At 15% tax rate, ET beats the other by $15,875.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + ET for your $10,000?

RMD: 50%ET: 50%
100% ET50/50100% RMD
Portfolio after 10yr
$62.5K
Annual income
$12,626.76/yr
Blended yield
20.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ET right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
ET
Analyst Ratings
1
Strong
27
Buy
4
Hold
Consensus: Buy
Price Target
$18.00
-8.1% upside vs current
Range: $17.00 — $19.00
Altman Z
1.3
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
ET buys
0
No recent congressional trades found for RMD or ET in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDET
Forward yield1.06%6.76%
Annual dividend / share$2.33$1.33
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%24.5%
Portfolio after 10y$31.7K$93.4K
Annual income after 10y$3,288.25$21,965.29
Total dividends collected$10.4K$64.0K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyBuy
Analyst price target$295.88$18.00

Year-by-year: RMD vs ET ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrET PortfolioET Income/yrGap
1← crossover$10,844$143.91$11,542$842.08$698.00ET
2$11,801$198.21$13,481$1,130.89$1.7KET
3$12,901$273.96$15,961$1,536.88$3.1KET
4$14,185$380.39$19,196$2,117.29$5.0KET
5$15,709$531.20$23,503$2,962.82$7.8KET
6$17,556$747.16$29,369$4,220.80$11.8KET
7$19,845$1,060.53$37,561$6,136.87$17.7KET
8$22,757$1,522.63$49,323$9,132.50$26.6KET
9$26,567$2,217.64$66,729$13,953.56$40.2KET
10$31,715$3,288.25$93,366$21,965.29$61.7KET

RMD vs ET: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

ETEnergy

Energy Transfer LP provides energy-related services. The company owns and operates approximately 11,600 miles of natural gas transportation pipeline, and three natural gas storage facilities in Texas and two natural gas storage facilities located in the state of Texas and Oklahoma; and 19,830 miles of interstate natural gas pipeline. It also sells natural gas to electric utilities, independent power plants, local distribution and other marketing companies, and industrial end-users. The company owns and operates natural gas gathering and natural gas liquid (NGL) pipeline, processing plant, and treating and conditioning facilities in Texas, New Mexico, West Virginia, Pennsylvania, Ohio, Oklahoma, Arkansas, Kansas, and Louisiana; natural gas gathering, oil pipeline, and oil stabilization facilities in South Texas; and a natural gas gathering system in Ohio, as well as transport and supplies water to natural gas producer in Pennsylvania. It owns approximately 5,215 miles of NGL pipeline; NGL and propane fractionation facilities; NGL storage facilities with working storage capacity of approximately 50 million barrels (MMBbls); and other NGL storage assets and terminal with an aggregate storage capacity of approximately 17 MMBbls. The company provides crude oil transportation, terminalling, acquisition, and marketing activities; and sells and distributes gasoline, middle distillate, and motor fuels and other petroleum product. It offers natural gas compression service; carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration, and British thermal unit management service; and manages coal and natural resources properties, as well as sells standing timber, leases coal-related infrastructure facilities, collects oil and gas royalty, and generate electrical power. The company was formerly known as Energy Transfer Equity, L.P. and changed its name to Energy Transfer LP in October 2018. The company was founded in 1996 and is headquartered in Dallas, Texas.

Full ET Calculator →
📬

Get this RMD vs ET comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.